TMEM116
gene geneOn this page
Also known as FLJ90167
Summary
TMEM116 (transmembrane protein 116, HGNC:25084) is a protein-coding gene on chromosome 12q24.13, encoding Transmembrane protein 116 (Q8NCL8).
Predicted to be involved in signal transduction. Predicted to be located in membrane.
Source: NCBI Gene 89894 — RefSeq curated summary.
At a glance
- GWAS associations: 9
- Clinical variants (ClinVar): 54 total
- MANE Select transcript:
NM_001193531
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:25084 |
| Approved symbol | TMEM116 |
| Name | transmembrane protein 116 |
| Location | 12q24.13 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | FLJ90167 |
| Ensembl gene | ENSG00000198270 |
| Ensembl biotype | protein_coding |
| Entrez | 89894 |
Gene structure
Transcript identifiers
Ensembl transcripts: 35 — 24 protein_coding, 4 nonsense_mediated_decay, 4 retained_intron, 3 protein_coding_CDS_not_defined
ENST00000355445, ENST00000437003, ENST00000546537, ENST00000546962, ENST00000547878, ENST00000548283, ENST00000549425, ENST00000549537, ENST00000550020, ENST00000550037, ENST00000550233, ENST00000550800, ENST00000550831, ENST00000551297, ENST00000552374, ENST00000552800, ENST00000552801, ENST00000552839, ENST00000716727, ENST00000716768, ENST00000718450, ENST00000880135, ENST00000880136, ENST00000880137, ENST00000880138, ENST00000880139, ENST00000880140, ENST00000880141, ENST00000880142, ENST00000880143, ENST00000880144, ENST00000880145, ENST00000880146, ENST00000932745, ENST00000963792
RefSeq mRNA: 4 — MANE Select: NM_001193531
NM_001193453, NM_001193531, NM_001294314, NM_138341
CCDS: CCDS55886, CCDS55887, CCDS9157
Canonical transcript exons
ENST00000552374 — 11 exons
| Exon | Start | End |
|---|---|---|
| ENSE00003282341 | 112013002 | 112013165 |
| ENSE00003459804 | 111937160 | 111937243 |
| ENSE00003494927 | 111932586 | 111932659 |
| ENSE00003498194 | 111943265 | 111943369 |
| ENSE00003500665 | 112003800 | 112003863 |
| ENSE00003545164 | 111938161 | 111938210 |
| ENSE00003632316 | 111933886 | 111934030 |
| ENSE00003694232 | 111991758 | 111991889 |
| ENSE00003785637 | 111936692 | 111936830 |
| ENSE00004030412 | 112005257 | 112005303 |
| ENSE00004030414 | 111931298 | 111931827 |
Expression profiles
Bgee: expression breadth ubiquitous, 226 present calls, max score 91.72.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 9.3468 / max 143.1427, expressed in 1703 samples.
FANTOM5 promoters (5 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 133319 | 8.2634 | 1694 |
| 133318 | 0.5117 | 149 |
| 133317 | 0.3423 | 106 |
| 133320 | 0.1989 | 79 |
| 133321 | 0.0303 | 7 |
Top tissues by expression
241 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| olfactory segment of nasal mucosa | UBERON:0005386 | 91.72 | gold quality |
| nasal cavity epithelium | UBERON:0005384 | 91.32 | gold quality |
| heart left ventricle | UBERON:0002084 | 90.34 | gold quality |
| heart right ventricle | UBERON:0002080 | 90.27 | gold quality |
| cardiac ventricle | UBERON:0002082 | 90.21 | gold quality |
| apex of heart | UBERON:0002098 | 90.13 | gold quality |
| metanephros cortex | UBERON:0010533 | 89.90 | gold quality |
| adult mammalian kidney | UBERON:0000082 | 89.83 | gold quality |
| calcaneal tendon | UBERON:0003701 | 89.78 | gold quality |
| left testis | UBERON:0004533 | 88.18 | gold quality |
| right testis | UBERON:0004534 | 87.75 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 87.67 | gold quality |
| testis | UBERON:0000473 | 87.42 | gold quality |
| cortex of kidney | UBERON:0001225 | 87.36 | gold quality |
| bronchial epithelial cell | CL:0002328 | 87.17 | gold quality |
| kidney epithelium | UBERON:0004819 | 87.14 | gold quality |
| kidney | UBERON:0002113 | 86.84 | gold quality |
| heart | UBERON:0000948 | 86.60 | gold quality |
| bronchus | UBERON:0002185 | 86.35 | gold quality |
| renal medulla | UBERON:0000362 | 86.00 | gold quality |
| nasal cavity mucosa | UBERON:0001826 | 85.90 | gold quality |
| skin of leg | UBERON:0001511 | 85.15 | gold quality |
| palpebral conjunctiva | UBERON:0001812 | 84.86 | gold quality |
| skin of abdomen | UBERON:0001416 | 84.52 | gold quality |
| ileal mucosa | UBERON:0000331 | 84.48 | gold quality |
| left ventricle myocardium | UBERON:0006566 | 84.27 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 84.20 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 84.12 | gold quality |
| right adrenal gland | UBERON:0001233 | 84.05 | gold quality |
| zone of skin | UBERON:0000014 | 83.82 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 10.78 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting TMEM116, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-5692A | 100.00 | 74.40 | 6850 |
| HSA-MIR-4789-3P | 99.99 | 70.75 | 2484 |
| HSA-MIR-150-5P | 99.99 | 66.69 | 1976 |
| HSA-MIR-6508-5P | 99.92 | 70.67 | 2465 |
| HSA-MIR-345-3P | 99.89 | 70.23 | 1421 |
| HSA-MIR-8067 | 99.86 | 69.59 | 2260 |
| HSA-MIR-4306 | 99.72 | 70.50 | 3630 |
| HSA-MIR-425-5P | 99.59 | 67.67 | 900 |
| HSA-MIR-17-3P | 99.55 | 66.77 | 1311 |
| HSA-MIR-203A-3P | 99.49 | 70.56 | 2806 |
| HSA-MIR-7151-5P | 99.37 | 67.82 | 613 |
| HSA-MIR-642A-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-642B-3P | 99.23 | 67.67 | 1258 |
| HSA-MIR-7113-3P | 98.75 | 65.71 | 1120 |
| HSA-MIR-5197-3P | 98.71 | 67.05 | 1905 |
| HSA-MIR-3921 | 97.81 | 67.45 | 1431 |
| HSA-MIR-7111-3P | 97.80 | 66.75 | 1467 |
| HSA-MIR-204-3P | 97.80 | 66.84 | 1656 |
| HSA-MIR-4646-5P | 97.70 | 66.84 | 1692 |
| HSA-MIR-4314 | 97.50 | 67.30 | 1369 |
| HSA-MIR-4653-5P | 97.22 | 67.72 | 1429 |
| HSA-MIR-2909 | 96.36 | 67.30 | 562 |
| HSA-MIR-4761-3P | 96.27 | 66.26 | 524 |
| HSA-MIR-1298-3P | 94.05 | 64.84 | 620 |
Literature-anchored findings (GeneRIF, showing 1)
- TMEM116 is required for lung cancer cell motility and metastasis through PDK1 signaling pathway. (PMID:34789718)
Cross-species orthologs
3 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | tmem116 | ENSDARG00000077155 |
| mus_musculus | Tmem116 | ENSMUSG00000029452 |
| rattus_norvegicus | Tmem116 | ENSRNOG00000027480 |
Paralogs (1): GPR157 (ENSG00000180758)
Protein
Protein identifiers
Transmembrane protein 116 — Q8NCL8 (reviewed: Q8NCL8)
All UniProt accessions (8): Q8NCL8, F8VNZ8, F8VP39, F8VQZ8, F8VRN7, F8VWU6, F8W1L7, G3V1Z3
UniProt curated annotations — full annotation on UniProt →
Subcellular location. Endoplasmic reticulum membrane Endoplasmic reticulum membrane.
Isoforms (3)
| UniProt ID | Names | Canonical? |
|---|---|---|
| Q8NCL8-1 | 1 | yes |
| Q8NCL8-2 | 2 | |
| Q8NCL8-3 | 3 |
RefSeq proteins (4): NP_001180382, NP_001180460, NP_001281243, NP_612350 (=MANE)
Domains & families (InterPro)
UniProt features (13 total): topological domain 4, transmembrane region 3, sequence conflict 2, splice variant 2, chain 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-Q8NCL8-F1 | 74.00 | 0.03 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 92 (showing top):
AREB6_03, YGCGYRCGC_UNKNOWN, GOCC_NUCLEAR_OUTER_MEMBRANE_ENDOPLASMIC_RETICULUM_MEMBRANE_NETWORK, GOCC_ORGANELLE_SUBCOMPARTMENT, KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP, chr12q24, THUM_SYSTOLIC_HEART_FAILURE_DN, RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_DN, KRIGE_RESPONSE_TO_TOSEDOSTAT_6HR_DN, WIERENGA_STAT5A_TARGETS_UP, WIERENGA_STAT5A_TARGETS_GROUP1, SERVITJA_LIVER_HNF1A_TARGETS_UP, WAKABAYASHI_ADIPOGENESIS_PPARG_RXRA_BOUND_8D, FORTSCHEGGER_PHF8_TARGETS_UP, CAMP_UP.V1_UP
GO Biological Process (2): signal transduction (GO:0007165), biological_process (GO:0008150)
GO Molecular Function (1): molecular_function (GO:0003674)
GO Cellular Component (3): endoplasmic reticulum membrane (GO:0005789), membrane (GO:0016020), cellular_component (GO:0005575)
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| cell communication | 1 |
| cellular process | 1 |
| signaling | 1 |
| regulation of cellular process | 1 |
| cellular response to stimulus | 1 |
| organelle membrane | 1 |
| nuclear outer membrane-endoplasmic reticulum membrane network | 1 |
| endoplasmic reticulum subcompartment | 1 |
| cellular anatomical structure | 1 |
Protein interactions and networks
STRING
1576 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| TMEM116 | NAA25 | Q14CX7 | 649 |
| TMEM116 | ACAD10 | Q6JQN1 | 647 |
| TMEM116 | TMEM72 | A0PK05 | 623 |
| TMEM116 | TMEM213 | A2RRL7 | 584 |
| TMEM116 | TMEM207 | Q6UWW9 | 575 |
| TMEM116 | HECTD4 | Q9Y4D8 | 544 |
| TMEM116 | TMEM25 | Q86YD3 | 543 |
| TMEM116 | TMEM253 | P0C7T8 | 540 |
| TMEM116 | TRAFD1 | O14545 | 512 |
| TMEM116 | ALDH2 | P05091 | 510 |
| TMEM116 | RTP3 | Q9BQQ7 | 507 |
| TMEM116 | TMEM61 | Q8N0U2 | 507 |
| TMEM116 | NDC1 | Q9BTX1 | 505 |
| TMEM116 | ZNF704 | Q6ZNC4 | 489 |
| TMEM116 | CWC27 | Q6UX04 | 471 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| TMEM116 | NRP1 | psi-mi:“MI:0915”(physical association) | 0.400 |
| TMEM116 | IGHA1 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (8): TMEM116 (Synthetic Lethality), TMEM116 (Negative Genetic), NRP1 (Affinity Capture-MS), RETSAT (Affinity Capture-MS), CLCN3 (Affinity Capture-MS), IGHA1 (Affinity Capture-MS), PDZD8 (Affinity Capture-MS), LCN1 (Affinity Capture-MS)
ESM2 similar proteins: A2BGS3, A6NGA9, E7F594, O36364, O60478, O60883, O95800, O95838, P03208, P16849, P31389, P34590, P35367, P49219, Q03613, Q09351, Q09964, Q09965, Q14439, Q16950, Q16951, Q2KI97, Q3U3F9, Q5FVG1, Q5IXF8, Q5UAW9, Q60755, Q64017, Q66615, Q66H29, Q6P7G9, Q6SW98, Q6X632, Q7TSN5, Q7TSN6, Q80W35, Q80WT4, Q8BNQ3, Q8C206, Q8CIM5
Diamond homologs: A2BGS3, Q8NCL8
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
54 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 45 |
| Likely benign | 2 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
2504 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 12:111937244:C:CC | acceptor_gain | 1.0000 |
| 12:111932743:C:CT | acceptor_gain | 0.9900 |
| 12:111936759:C:CT | donor_gain | 0.9900 |
| 12:111936760:T:TT | donor_gain | 0.9900 |
| 12:111937158:A:AC | donor_gain | 0.9900 |
| 12:111937159:C:CC | donor_gain | 0.9900 |
| 12:111937239:TCAGG:T | acceptor_gain | 0.9900 |
| 12:111937240:CAGG:C | acceptor_gain | 0.9900 |
| 12:111937240:CAGGC:C | acceptor_gain | 0.9900 |
| 12:111990718:A:AC | donor_gain | 0.9900 |
| 12:111990719:C:CC | donor_gain | 0.9900 |
| 12:112005250:AACAT:A | donor_loss | 0.9900 |
| 12:112005251:ACAT:A | donor_loss | 0.9900 |
| 12:112005252:CATA:C | donor_loss | 0.9900 |
| 12:112005253:AT:A | donor_loss | 0.9900 |
| 12:112005254:TA:T | donor_loss | 0.9900 |
| 12:112005256:C:CT | donor_loss | 0.9900 |
| 12:112005304:C:CA | acceptor_loss | 0.9900 |
| 12:112005304:C:CC | acceptor_gain | 0.9900 |
| 12:112013030:G:GA | donor_gain | 0.9900 |
| 12:112013605:ACAAG:A | donor_loss | 0.9900 |
| 12:112013606:CAAGG:C | donor_loss | 0.9900 |
| 12:112013607:AAGG:A | donor_loss | 0.9900 |
| 12:112013608:AG:A | donor_loss | 0.9900 |
| 12:112013609:GG:G | donor_loss | 0.9900 |
| 12:112013611:T:G | donor_loss | 0.9900 |
| 12:111937589:T:A | donor_gain | 0.9800 |
| 12:111943343:G:C | acceptor_gain | 0.9800 |
| 12:111946989:A:C | acceptor_gain | 0.9800 |
| 12:112005253:ATACC:A | acceptor_loss | 0.9800 |
AlphaMissense
2188 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 12:111936707:G:C | S99R | 0.988 |
| 12:111936707:G:T | S99R | 0.988 |
| 12:111936709:T:G | S99R | 0.988 |
| 12:111936719:G:C | S95R | 0.983 |
| 12:111936719:G:T | S95R | 0.983 |
| 12:111936721:T:G | S95R | 0.983 |
| 12:111933905:G:C | F146L | 0.956 |
| 12:111933905:G:T | F146L | 0.956 |
| 12:111933907:A:G | F146L | 0.956 |
| 12:111937243:G:C | S30R | 0.954 |
| 12:111937243:G:T | S30R | 0.954 |
| 12:111938162:T:G | S30R | 0.954 |
| 12:111931806:C:G | G185R | 0.952 |
| 12:111933901:A:G | C148R | 0.950 |
| 12:111933898:A:G | C149R | 0.945 |
| 12:111933892:C:G | G151R | 0.941 |
| 12:111931712:A:G | L216S | 0.940 |
| 12:111931795:G:C | N188K | 0.935 |
| 12:111931795:G:T | N188K | 0.935 |
| 12:111937188:A:G | C49R | 0.934 |
| 12:111931794:A:G | C189R | 0.925 |
| 12:111931699:C:A | Q220H | 0.922 |
| 12:111931699:C:G | Q220H | 0.922 |
| 12:111937187:C:G | C49S | 0.915 |
| 12:111937188:A:T | C49S | 0.915 |
| 12:111933896:G:C | C149W | 0.911 |
| 12:111936716:A:C | F96L | 0.911 |
| 12:111936716:A:T | F96L | 0.911 |
| 12:111936718:A:G | F96L | 0.911 |
| 12:111937183:G:C | F50L | 0.909 |
dbSNP variants (sampled 300 via entrez): RS1000064098 (12:111940887 T>C), RS1000068238 (12:111911579 C>A,T), RS1000092907 (12:111962323 T>C), RS1000131772 (12:111961537 C>T), RS1000134823 (12:112009857 A>C), RS1000170946 (12:111990983 G>A), RS1000179710 (12:111980100 A>G), RS1000186867 (12:111932870 G>C), RS1000213077 (12:111990397 A>G), RS1000238300 (12:111983136 TA>T,TAA), RS1000284367 (12:111996528 C>T), RS1000285882 (12:111918224 C>T), RS1000376907 (12:111984630 A>C), RS1000461424 (12:111961154 A>G), RS1000463836 (12:111924991 C>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
9 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST004131_54 | Inflammatory bowel disease | 2.000000e-09 |
| GCST004132_84 | Crohn’s disease | 7.000000e-07 |
| GCST004603_120 | Platelet count | 4.000000e-15 |
| GCST005951_1 | Body mass index | 4.000000e-12 |
| GCST005951_75 | Body mass index | 2.000000e-11 |
| GCST006231_55 | Mean arterial pressure | 6.000000e-09 |
| GCST007876_6 | Estimated glomerular filtration rate | 2.000000e-11 |
| GCST010083_300 | Hemoglobin levels | 2.000000e-53 |
| GCST012044_4 | Tea consumption | 1.000000e-07 |
EFO canonical traits (5, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0004309 | platelet count |
| EFO:0004340 | body mass index |
| EFO:0006340 | mean arterial pressure |
| EFO:0004509 | hemoglobin measurement |
| EFO:0010091 | tea consumption measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
32 total (human), top 30 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Arsenic | affects methylation, affects cotreatment, increases abundance, increases expression | 2 |
| Nickel | decreases expression | 2 |
| Aflatoxin B1 | decreases methylation, affects expression | 2 |
| methylmercuric chloride | decreases expression | 1 |
| nobiletin | increases expression | 1 |
| arsenite | increases reaction, affects binding | 1 |
| sulforaphane | increases expression | 1 |
| sodium arsenite | affects cotreatment, increases abundance, increases expression | 1 |
| perfluorooctane sulfonic acid | increases expression | 1 |
| ICG 001 | increases expression | 1 |
| jinfukang | increases expression | 1 |
| Sunitinib | increases expression | 1 |
| Acetaminophen | increases expression | 1 |
| Benzo(a)pyrene | decreases expression | 1 |
| Diuron | decreases expression | 1 |
| Doxorubicin | decreases expression | 1 |
| Estradiol | decreases expression | 1 |
| Methyl Methanesulfonate | increases expression | 1 |
| Methylcholanthrene | affects binding, increases reaction | 1 |
| Phthalic Acids | decreases methylation | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | increases expression | 1 |
| Tretinoin | decreases expression | 1 |
| Tunicamycin | increases expression | 1 |
| Valproic Acid | decreases methylation, increases expression | 1 |
| Oxyquinoline | decreases expression | 1 |
| Cyclosporine | increases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Thapsigargin | increases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.